For US Healthcare Professionals Only
Watch Josef Smolen, professor of Internal Medicine and Chairman of the Division of Rheumatology at the Medical University of Vienna, discuss new data about RF and how it may be a biomarker that allows better understanding of which patients will respond better to a particular therapy.
Chapters
Name
Welcome, Introduction, Disclosures, Agenda
Chapter Time
00:00:00
Chapter Seconds
0
Name
What is Rheumatoid Factor (RF)?
Chapter Time
00:01:00
Chapter Seconds
60
Name
Unmet Need in RA Patients with High RF
Chapter Time
00:04:42
Chapter Seconds
282
Name
Latest Data: Clinical Outcomes in RA Patients with High RF Treatment with TNFis
Chapter Time
00:09:43
Chapter Seconds
583
Name
Latest Insights: Understanding How Different TNFis May Impact Outcomes in Patients
Chapter Time
00:13:16
Chapter Seconds
796
Name
CIMZIA Important Safety Information
Chapter Time
00:15:23
Chapter Seconds
923
Name
Summary, Acknowledgements, and Questions
Chapter Time
00:15:38
Chapter Seconds
938